R. Cirocco

发表

Microangiopathy in kidney and simultaneous pancreas/kidney recipients treated with tacrolimus: evidence of endothelin and cytokine involvement.

A. Tzakis, G. Ciancio, G. Burke, 1999, Transplantation.

Tacrolimus-related microangiopathy in kidney and simultaneous pancreas-kidney recipients: evidence of endothelin and cytokine involvement.

A. Tzakis, G. Ciancio, G. Burke, 1998, Transplantation proceedings.

Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine

E. Schiff, K. Reddy, S. Nishida, 2003, Transplantation.

A novel approach to detect donor/recipent immune responses between HLA-identical pairs.

G. Ciancio, G. Burke, A. Rosen, 2005, Human immunology.

The impact of hepatitis C virus infection on renal allograft recipients.

G. Burke, D. Roth, Joshua Miller, 1994, Kidney international.

FoxP3 mRNA Transcripts and Regulatory Cells in Renal Transplant Recipients 10 Years After Donor Marrow Infusion

B. Blomberg, C. Ricordi, J. Gaynor, 2007, Transplantation.

Immune responses and their regulation by donor bone marrow cells in clinical organ transplantation.

B. Blomberg, C. Ricordi, A. Tzakis, 2003, Transplant immunology.

Donor bone marrow infusions are tolerogenic in human renal transplantation.

C. Ricordi, N. Kenyon, A. Tzakis, 2001, Transplantation proceedings.

Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients.

C. Ricordi, N. Kenyon, A. Tzakis, 1998, Transplantation.

The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients.

C. Ricordi, A. Tzakis, G. Ciancio, 1997, The Journal of clinical investigation.

Assessment of the effects of cadaveric donor bone marrow on chimerism in kidney transplant recipients by the polymerase chain reaction-flow technique.

C. Ricordi, A. Tzakis, G. Ciancio, 1997, Transplantation proceedings.

PCR-flow analysis used to detect the levels of chimerism in peripheral blood of bone-marrow infused organ allograft recipients at the time of rejection episodes.

C. Ricordi, A. Tzakis, G. Ciancio, 1997, Transplantation proceedings.

An assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry.

C. Ricordi, A. Tzakis, G. Ciancio, 1996, Transplantation.

Transplant-associated autoimmune mechanisms in human hepatitis C virus infection

A. Tzakis, G. Burke, D. Roth, 2005, Journal of Clinical Immunology.

Transmission of hepatitis C virus by kidney transplantation: impact of perfusion techniques and course of viremia post transplant

G. Burke, D. Roth, Joshua Miller, 2004, Pediatric Nephrology.

A Randomized Trial of Three Renal Transplant Induction Antibodies: Early Comparison of Tacrolimus, Mycophenolate Mofetil, and Steroid Dosing, and Newer Immune-Monitoring1

J. Gaynor, A. Tzakis, G. Ciancio, 2005, Transplantation.

Early development of acute myelogenous leukemia following kidney transplantation: possible role of multiple serum cytokines.

G. Burke, D. Roth, Joshua Miller, 1995, Leukemia & lymphoma.

Post-transplant lymphoproliferative disease in kidney transplant patients in the new immunosuppressive era.

G. Ciancio, G. Burke, D. Roth, 1997, Clinical transplantation.

Inhibition of NF-KappaB during human dendritic cell differentiation generates anergy and regulatory T cell activity for one -but not two- HLA-DR mismatches

B. Blomberg, Kelvin P Lee, Joshua Miller, 2008 .

Inhibition of NF-kappa B during human dendritic cell differentiation generates anergy and regulatory T-cell activity for one but not two human leukocyte antigen DR mismatches.

B. Blomberg, Kelvin P Lee, J. Gaynor, 2007, Human immunology.

The presence of hepatitis B core antibody does not preclude kidney donation: lack of viral DNA in the serum and biopsies of core antibody-positive donors and clinical follow-up.

A. Tzakis, G. Burke, V. Esquenazi, 1997, Transplantation.

Successful treatment of posttransplant lymphoproliferative disease with prolonged rituximab treatment in intestinal transplant recipients

T. Berney, P. Ruiz, S. Nishida, 2002, Transplantation.

De novo membranoproliferative glomerulonephritis in hepatitis C virus-infected renal allograft recipients.

P. Ruiz, G. Burke, D. Roth, 1995, Transplantation.

Prospective longitudinal assessment of hepatitis C virus infection after renal transplantation.

G. Burke, D. Roth, V. Esquenazi, 1995, Transplantation proceedings.

DEPLETION OF HEPATITIS C VIRUS FROM PROCURED KIDNEYS USING PULSATILE PERFUSION PRESERVATION1,2

G. Burke, D. Roth, Joshua Miller, 1994, Transplantation.

Effect of cyclosporine A on serum tumor necrosis factor alpha in new-onset type I (insulin-dependent) diabetes mellitus.

J. Skyler, G. Burke, A. Rabinovitch, 1994, Journal of diabetes and its complications.

Early graft loss secondary to massive hemorrhagic necrosis following orthotopic liver transplantation. Evidence for cytokine-mediated univisceral Shwartzman reaction.

E. Schiff, P. Ruiz, A. Tzakis, 1996, Transplantation.

Association of interleukin-10 with rejection-sparing effect in septic kidney transplant recipients.

G. Ciancio, G. Burke, D. Roth, 1996, Transplantation.

Immunophenotyping and cellular immune responses of cadaveric donor bone marrow cells.

C. Ricordi, A. Tzakis, V. Esquenazi, 1998, Transplantation proceedings.

Liver transplantation for cirrhosis following jejuno-ileal bypass--regional cytokine differences associated with pathological changes in the transplant liver.

E. Schiff, G. Burke, Joshua Miller, 1992, Transplantation.

Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa‐2b and ribavirin therapy using tissue hepatitis C virus reverse transcriptase polymerase chain reaction testing

E. Schiff, A. Khaled, P. Bejarano, 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Hepatitis C in liver transplantation: preliminary study of prognostic factors

E. Schiff, V. Esquenazi, J. Nery, 1994, Transplant international : official journal of the European Society for Organ Transplantation.

Adenovirus Infection in Pediatric Liver and Intestinal Transplant Recipients: Utility of DNA Detection by PCR

A. Tzakis, P. Ruiz, Tomoaki Kato, 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

In situ enzymatic oligonucleotide amplification of hepatitis C virus-RNA in liver biopsy specimens (reverse transcriptase in situ polymerase chain reaction) after orthotopic liver transplantation for hepatitis C-related liver disease.

K. Reddy, M. Berho, A. Tzakis, 1998, Transplantation.

Recurrent hepatitis C infection following orthotopic liver transplantation is predicted by posttransplant serum and hepatic allograft viral titers.

E. Schiff, K. Reddy, A. Tzakis, 1997, Transplantation proceedings.

A prospective study of hepatitis C virus infection in renal allograft recipients.

G. Ciancio, G. Burke, D. Roth, 1996, Transplantation.

Activated cytokine pattern in hepatorenal syndrome: fall in levels after successful orthotopic liver transplantation.

E. Schiff, G. Burke, D. Roth, 1993, Transplantation proceedings.

Polyomavirus PCR monitoring in renal transplant recipients: detection in blood is associated with higher creatinine values.

A. Tzakis, G. Burke, D. Roth, 2001, Transplantation proceedings.

Assessment of homozygosity in HLA-class I antigens and their distribution/quantitation in subpopulations of T cells by flow cytometry.

A. Tzakis, V. Esquenazi, J. Miller, 1996, Transplantation proceedings.

Kidney recipient CMV incidence in the gancyclovir era: monitoring viral DNA by a CMV-PCR assay.

G. Ciancio, G. Burke, V. Esquenazi, 1999, Transplantation proceedings.

Rejection in HLA-identical living related donor kidney transplants: lack of predictive immunologic parameters.

G. Burke, D. Roth, V. Esquenazi, 1994, Transplantation.

Donor bone marrow infusion in simultaneous pancreas/kidney transplant recipients: a preliminary study.

C. Ricordi, R. Alejandro, G. Selvaggi, 1995, Transplantation proceedings.

Cytokine analysis in Atlantic bottlenose dolphins

G. Bossart, C. Bigger, R. Cirocco, 1997 .

M7 11:45 Cytokine analysis in atlantic bottlenose dolphins

C. Bigger, R. Cirocco, 1997 .

Donor bone marrow infusion in simultaneous pancreas/kidney transplantation with OKT3 induction: evidence for augmentation of chimerism.

J. Skyler, C. Ricordi, R. Alejandro, 1997, Transplantation proceedings.

Evidence for microchimerism in peripheral blood, bone marrow, and skin following donor bone marrow/kidney-pancreas transplantation at 3 years.

C. Ricordi, R. Alejandro, A. Tzakis, 1998, Transplantation proceedings.

Human donor bone marrow cells can enhance hyporeactivity in renal transplantation using maintenance FK 506 and OKT3 induction therapy.

C. Ricordi, A. Tzakis, G. Ciancio, 1996, Transplantation proceedings.

Cytomegalovirus prophylaxis with valganciclovir in kidney, pancreas–kidney, and pancreas transplantation

G. Ciancio, D. Roth, W. Kupin, 2004, Clinical transplantation.

Congenital Neutropenia: A Case Study

J. Jimenez, A. Yunis, S. Toledano, 1990, The American journal of pediatric hematology/oncology.

Association of engraftment and islet cell function in bone marrow infused diabetic solid organ recipients

C. Ricordi, R. Alejandro, A. Tzakis, 1996 .

Differentiation of regulatory myeloid and T-cells from adult human hematopoietic stem cells after allogeneic stimulation

J. Mathew, R. Cirocco, Jes M. Sanders, 2024, Frontiers in immunology.